Literature DB >> 9815712

Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.

D J Lee1, W M Koch, G Yoo, M Lango, A Reed, J Califano, J A Brennan, W H Westra, M Zahurak, D Sidransky.   

Abstract

We screened 73 primary head and neck squamous cell carcinoma (HNSCC) specimens for loss of heterozygosity (LOH) on chromosome 14q. Analysis of 20 polymorphic microsatellite markers identified 29 (40%) HNSCCs exhibiting LOH of 14q in at least one locus. Six tumors had probable monosomy of 14q, displaying allelic loss for all informative markers tested, and 23 demonstrated partial losses on 14q. Fine mapping with 1-10 additional markers revealed two poorly defined regions of loss (4-7 cM) at 14q13-21 and 14q31-32.1 in seven tumors. In 53 patients with previously untreated tumors treated with curative intent, LOH of 14q in these tumors correlated with poor survival. Compared to patients with tumors that retain heterozygosity of 14q, those with 14q LOH had a 3-fold increased risk of death in multivariate analysis (hazards ratio, 3.2; 95% confidence interval = 1.2-8.4). These data have confirmed a high frequency of chromosome 14q loss in HNSCC and suggest that LOH of any region on chromosome 14q is an indicator of poor outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9815712

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

1.  Genetic imbalances with impact on survival in head and neck cancer patients.

Authors:  U Bockmühl; K Schlüns; I Küchler; S Petersen; I Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Genome-wide prediction of imprinted murine genes.

Authors:  Philippe P Luedi; Alexander J Hartemink; Randy L Jirtle
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

Review 3.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

4.  Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas.

Authors:  Davut Pehlivan; Esra Gunduz; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Beyhan Cengiz; Rosario S Rivera; Kunihiro Fukushima; Sukru Palanduz; Sukru Ozturk; Noboru Yamanaka; Kenji Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-03       Impact factor: 4.553

5.  MicroRNA alterations in head and neck squamous cell carcinoma.

Authors:  Steven S Chang; Wei Wen Jiang; Ian Smith; Luana M Poeta; Shahnaz Begum; Chad Glazer; Shannon Shan; William Westra; David Sidransky; Joseph A Califano
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

Review 6.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.

Authors:  Yu Chen; Chu Chen
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

7.  Loss of 14q chromosome in oligodendroglial and astrocytic tumors.

Authors:  Charles Dichamp; Sophie Taillibert; Lucinda Aguirre-Cruz; Julie Lejeune; Yannick Marie; Michèle Kujas; Jean-Yves Delattre; Khe Hoang-Xuan; Marc Sanson
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

8.  Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.

Authors:  Pawadee Lohavanichbutr; John Houck; David R Doody; Pei Wang; Eduardo Mendez; Neal Futran; Melissa P Upton; F Christopher Holsinger; Stephen M Schwartz; Chu Chen
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy.

Authors:  Mary E. Barcus; Celeste N. Powers
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

10.  CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Zhien Feng; Wei Guo; Chenping Zhang; Qin Xu; Ping Zhang; Jian Sun; Hanguang Zhu; Zhonghe Wang; Jiang Li; Lizhen Wang; Bingshun Wang; Guoxin Ren; Tong Ji; Wenyong Tu; Xihu Yang; Weiliu Qiu; Li Mao; Zhiyuan Zhang; Wantao Chen
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.